Maze Therapeutics, Inc. · NASDAQ:MAZE

Paradigm Biocapital Advisors LP's stake in Maze Therapeutics, Inc. fell below 5% (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Paradigm Biocapital Advisors LP's stake in Maze Therapeutics, Inc. fell below 5%, 0 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
0%
Shares
0
Intent
Passive
What changed
Fell below 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Paradigm BioCapital Advisors LP0%0
Paradigm BioCapital Advisors GP LLC0%0
Senai Asefaw, M.D.0%0
Paradigm BioCapital International Fund Ltd.0%0

Source

View original at SEC

Related